Stock Track | Pacific Biosciences Soars 8.04% on Tuesday Following Analyst Price Target Updates

Stock Track
2025/02/18

Pacific Biosciences (PACB) saw its stock soar 8.04% on Tuesday's trading session, driven by positive analyst ratings and price target updates.

Stephens & Co. maintained a $2.50 price target on PACB, expressing confidence in the company's prospects. Meanwhile, Morgan Stanley reiterated a "Hold" rating on the stock, setting a $2.00 price target.

The updates from these analysts reflect optimism surrounding Pacific Biosciences' future performance, boosting investor sentiment and driving the stock's significant upward movement during Tuesday's trading.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10